Delivery Order SPE2DB22D1017-SPE2DB24FF3FD

Award Date 2/23/24
Potential Completion Date 2/26/24
Potential Value $22K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB22D3004|SPE2DB25FNM42, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $25,536.59, is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. This is a firm fixed-price delivery order contract with a completion date of November 14, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp is...
This federal contract award, with the ID SPE2DB20D1109|SPE2DB25FN37Q, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $15,311.79 firm fixed-price delivery order is for the pharmaceutical product NURTEC ODT 75 MG TABLET 8S. The contract has an ultimate completion date of January 9, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical...
This federal contract award, with ID SPE2DB22D3004|SPE2DB24FNE92, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $20,183.87, is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. The contract has an ultimate completion date of October 20, 2023 and is a Firm Fixed Price Delivery Order. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award, identified as SPE2DB20D1109|SPE2DB24FM99N, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $15,240.67 firm fixed-price delivery order is for the supply of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. The contract has an ultimate completion date of October 31, 2023 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
This federal contract award, with ID SPE2DB25D3005|SPE2DB25FQARD, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $23,946.48 firm fixed-price delivery order is for the supply of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. The contract has an ultimate completion date of November 21, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal...
This federal contract award, with ID SPE2DB20D1110|SPE2DB24FJ74R, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $4,495.10 firm fixed-price delivery order is for the pharmaceutical product NURTEC ODT 75 MG TABLET 8S. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical and medical supplies to...
This federal contract award, with ID SPE2DB22D1002|SPE2DB24FLDF1, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $7,347.90 contract is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of June 10, 2024. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp, the prime...
This federal contract award, with ID SPE2DB20D1109|SPE2DB25FN48F, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $7,534.60 firm fixed-price delivery order is for the provision of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a vehicle for supplying a...
This federal contract award, with ID SPE2DB20D3104|SPE2DB24FV7A2, was issued by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp. The contract, valued at $5,444.58, is a firm-fixed-price delivery order for the pharmaceutical product NURTEC ODT 75 MG TABLET 8S. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly...
This federal contract award, with ID SPE2DB22D3016|SPE2DB25FAHN8, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,020.32 firm fixed-price delivery order is for the supply of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. The contract has an ultimate completion date of December 30, 2024 and was awarded on December 27, 2024. This appears to be a delivery order under a larger...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FF3FD
    Delivery Order

This federal contract award, with an ID of SPE2DB22D1017|SPE2DB24FF3FD, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $21,715.47 firm fixed-price delivery order is for the pharmaceutical product NURTEC ODT 75 MG TABLET 8S, with a period of performance ending on February 26, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that provides a broad range of medical products, including specialty medications, generics, and medical supplies, to federal government agencies, with a significant focus on supporting military and veterans' healthcare programs through its Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 through November 2026.

Generated 5/14/25, 10:37 AM